beta

GILD

Gilead Sciences, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

Market Cap: 90.5 Billion

Primary Exchange: NASDAQ

Website: https://www.gilead.com/

Shares Outstanding: 1.25 Billion

Float: 0

Dividend: 2.9173860897687263 (0.04%)

Beta: 0.5059652119560842

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Ethical Flags

Longest drawdown: 2619 trading days

From: 2015-06-23 To: 2024-03-07

Lowest Point:

Akero Therapeutics Readies $75 Million IPO

via: SeekingAlpha at 2019-06-13 09:11:26:000

Quick Take Akero Therapeutics ( AKRO ) has filed to raise gross proceeds of $75.0 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing a treatment for metabolic diseases with high unmet clinical needs, with an initial focus on non-alcoholic steato… read more...

June 2019 Stock Considerations

via: SeekingAlpha at 2019-06-12 23:24:27:000

After a wild May we seem to be trending back up in June. Of course, anyone in the DGI space already knows that these daily, weekly and monthly swings really don't matter to anyone with a very long-term time horizon. All we can do in the meantime is watch the market swing, stay in the game, fin… read more...

BIIB Is For Buy-O-Gen

via: SeekingAlpha at 2019-06-12 06:30:36:000

Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...

Gilead Hopes To Continue Sales Expansion Of Yescarta - Results From KTE-X19 Step In The Right Direction

via: SeekingAlpha at 2019-06-11 13:29:35:000

Gilead Sciences ( GILD ) reported final results from its phase 1 study using its CAR-T cell therapy KTE-X19 to treat patients with relapsed/refractory acute lymphoblastic leukemia ((ALL)). This was early clinical data that was presented at the American Society for Clinical Oncology ((ASCO)) … read more...

How To Find Undervalued Stocks In The Healthcare Sector

via: SeekingAlpha at 2019-06-10 12:10:41:000

The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...

Dividend Challenger Highlights: Week Of June 9

via: SeekingAlpha at 2019-06-10 02:40:50:000

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2019-09-12 2019-09-27 2019-09-13 2019-07-30 0.63 No Change QoQ
2019-06-13 2019-06-27 2019-06-14 2019-05-02 0.63 No Change QoQ
2019-03-14 2019-03-28 2019-03-15 2019-02-04 0.63 Increase
2018-12-13 2018-12-28 2018-12-14 2018-10-25 0.57 No Change QoQ
2018-09-13 2018-09-27 2018-09-14 2018-07-25 0.57 No Change QoQ
2018-06-14 2018-06-28 2018-06-15 2018-05-01 0.57 No Change QoQ
2018-03-15 2018-03-29 2018-03-16 2018-02-06 0.57 Increase
2017-12-14 2017-12-28 2017-12-15 2017-10-26 0.52 No Change QoQ
2017-09-14 2017-09-28 2017-09-15 2017-07-26 0.52 No Change QoQ
2017-06-14 2017-06-29 2017-06-16 2017-05-02 0.52 No Change QoQ
2017-03-14 2017-03-30 2017-03-16 2017-02-07 0.52 Increase
2016-12-13 2016-12-29 2016-12-15 2016-11-01 0.47 No Change QoQ
2016-09-14 2016-09-29 2016-09-16 2016-07-25 0.47 No Change QoQ
2016-06-14 2016-06-29 2016-06-16 2016-04-28 0.47 Increase
2016-03-14 2016-03-30 2016-03-16 2016-02-02 0.43 No Change QoQ
2015-12-14 2015-12-30 2015-12-16 2015-10-27 0.43 No Change QoQ
2015-09-14 2015-09-29 2015-09-16 2015-07-28 0.43 No Change QoQ
2015-06-12 2015-06-29 2015-06-16 2015-04-30 0.43 No Change QoQ
2019-12-12 2019-12-30 2019-12-13 2019-10-23 0.63 Cash
2020-03-12 2020-03-30 2020-03-13 2020-02-03 0.68 Cash
2020-06-11 2020-06-29 2020-06-12 2020-04-29 0.68 Cash
2020-09-14 2020-09-29 2020-09-15 2020-07-30 0.68 Cash
2020-12-14 2020-12-30 2020-12-15 2020-10-28 0.6800000071525574 Cash
2021-03-12 2021-03-30 2021-03-15 2021-02-04 0.71 Cash
2021-06-14 2021-06-29 2021-06-15 2021-04-29 0.71 Cash
2021-09-14 2021-09-29 2021-09-15 2021-07-29 0.71 Cash
2021-12-14 2021-12-30 2021-12-15 2021-10-28 0.71 Cash
2022-03-14 2022-03-30 2022-03-15 2022-02-01 0.73 Cash
2022-06-14 2022-06-29 2022-06-15 0.73 Cash
2022-09-14 2022-09-29 2022-09-15 2022-08-02 0.73 Cash
2022-12-14 2022-12-29 2022-12-15 2022-10-27 0.73 Cash
2023-03-14 2023-03-30 2023-03-15 2023-02-02 0.75 Cash
2023-06-14 2023-06-29 2023-06-15 2023-04-27 0.75 Cash
2023-09-14 2023-09-28 2023-09-15 2023-08-03 0.75 Cash
2023-12-14 2023-12-28 2023-12-15 2023-11-07 0.75 Cash
2024-03-14 2024-03-28 2024-03-15 2024-02-06 0.77 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2013-01-28 2012-12-10 2013-01-07 2013-01-25 00:00:00 -0500 0.5 2.0 1.0
Data provided by IEX Cloud